Evidence map›Paper›PMID 38686055›Full record

ArticleOncology research2024

Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of

Zhen Liu, Liangwang Yang, Zhengxing Xie, Hui Yu, Tianyi Gu, Daoming Shi, Ning Cai, Shenghua Zhuo

Open access · bronzeAbstract read
In one paragraph

Article in Oncology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhen LiuDepartment of Neurosurgery, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Liangwang YangDepartment of Neurosurgery, First Affiliated Hospital of Hainan Medical University, Haikou, 570100, China.
Zhengxing XieDepartment of Neurosurgery, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Hui YuDepartment of Cardiothoracic Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Tianyi GuDepartment of Cardiothoracic Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Daoming ShiDepartment of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Ning CaiDepartment of Neurosurgery, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Shenghua ZhuoDepartment of Neurosurgery, First Affiliated Hospital of Hainan Medical University, Haikou, 570100, China.
Jiangsu University · CNHainan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical data indicates that glioma patients have poor treatment outcomes and clinical prognosis. The role of olfactory signaling pathway-related genes (OSPRGs) in glioma has not been fully elucidated. In this study, we aimed to investigate the role and relationship between OSPRGs and glioma. Univariate and multivariate Cox regression analyses were performed to assess the relationship between OSPRGs and the overall survival of glioma based on public cohorts, and the target gene (G Protein Subunit Alpha L,

Indexed as

Biomarkers, TumorBrain NeoplasmsDNA MethylationGliomaCohort StudiesFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPrognosisTumor MicroenvironmentBiomarkers, TumorGliomaGNALImmunotherapy/chemotherapy responseOlfactionTumor immune microenvironment

Identifiers

PMID38686055
PMCPMC11055992
OpenAlexW4391488013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.